Cargando…
Thymic Involution After Radioiodine Therapy for Graves Disease: Relationships With Serum Thyroid Hormones and TRAb
CONTEXT: The mechanisms of thymic hyperplasia in Graves disease and its involution after radioiodine (I-131) therapy remain unknown. OBJECTIVE: To examine whether computed tomography (CT) findings of the thymus in patients with Graves disease change before and 6 months after I-131 therapy and to elu...
Autores principales: | Jinguji, Megumi, Nakajo, Masayuki, Nakajo, Masatoyo, Koriyama, Chihaya, Yoshiura, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686677/ https://www.ncbi.nlm.nih.gov/pubmed/29264536 http://dx.doi.org/10.1210/js.2017-00182 |
Ejemplares similares
-
I-131 false-positive uptake in a thymic cyst with expression of the sodium-iodide symporter: A case report
por: Yano, Erina, et al.
Publicado: (2022) -
The effect of radioiodine treatment on the characteristics of TRAb in Graves’ disease
por: Fang, Ya, et al.
Publicado: (2021) -
Application of (123)I-MIBG myocardial maximum standardized uptake value to characterize cardiac function in patients with pheochromocytoma: comparison with echocardiography
por: Nakajo, Masatoyo, et al.
Publicado: (2022) -
Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres
por: Shahida, Bushra, et al.
Publicado: (2021) -
Value of Patlak Ki images from (18)F-FDG-PET/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis
por: Nakajo, Masatoyo, et al.
Publicado: (2021)